Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf)

Clinical trial NCT03441633 · COMPLETED

Trial details

NCT number: NCT03441633
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation

Start date: 2016-02-18
Primary completion: 2017-03-08
Enrollment: 51690

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.